Stay updated with breaking news from Ibrahim Kassis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative...
Nathan Jeffay is The Times of Israel's health and science correspondent An illustration of the impact of multiple sclerosis on the brain. On the left, a brain with white areas denoting MS damage. On the upper right, close-up of regular myelin, and below, damaged myelin. (wildpixel via iStock by Getty Images) Clinical trials for a new stem cell treatment have “frozen” the progression of multiple sclerosis, and left some patients in better condition than before they were injected, even ditching walking sticks, according to Jerusalem doctors. The biopharmaceutical company NeuroGenesis has ...